TRCT
RDHL

Tower Research Capital (TRC)’s Redhill Biopharma RDHL Stock Holding History

Tower Research Capital (TRC)’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Hold
0
– – – 6310
2023
Q1 		– Hold
0
– – – 6197
2022
Q4 		– Sell
-12
Closed -$6K – 6282
2022
Q3 		$6K Buy
12
+8
+200% +$6.97K ﹤0.01% 5039
2022
Q2 		$4K Sell
4
-3
-43% -$4.12K ﹤0.01% 5247
2022
Q1 		$17K Sell
7
-2
-22% -$4.74K ﹤0.01% 3702
2021
Q4 		$24K Sell
9
-18
-67% -$72K ﹤0.01% 3473
2021
Q3 		$123K Buy
27
+24
+800% +$163K ﹤0.01% 2217
2021
Q2 		$23K Buy
3
+1
+50% +$6.9K ﹤0.01% 3766
2021
Q1 		$13K Buy
+2
New +$16.8K ﹤0.01% 4216
2020
Q4 		– Hold
0
– – – 4820
2020
Q1 		– Hold
0
– – – 3747
2019
Q4 		– Sell
-1
Closed -$6.39K – 4225
2019
Q3 		$8K Hold
1
– – ﹤0.01% 3088
2019
Q2 		$5K Hold
1
– – ﹤0.01% 2955
2019
Q1 		$12K Buy
+1
New +$7.91K ﹤0.01% 2587
2016
Q4 		– Hold
0
– -$1K – 4292
2016
Q3 		– Sell
-1
Closed -$14K – 3349
2016
Q2 		$7K Buy
+1
New +$11.6K ﹤0.01% 3160
2016
Q1 		– Hold
0
– – – 2919
2015
Q4 		– Sell
-1
Closed -$16K – 4952
2015
Q3 		$16K Buy
+1
New +$14.8K ﹤0.01% 1936
2015
Q2 		– Sell
-3
Closed -$38K – 4913
2015
Q1 		$38K Buy
3
+2
+200% +$28.4K ﹤0.01% 1703
2014
Q4 		$15K Buy
+1
New +$10.4K ﹤0.01% 1803
2014
Q3 		– Sell
-1
Closed -$14.4K – 3311
2014
Q2 		$16K Hold
1
– – ﹤0.01% 1988
2014
Q1 		$11K Buy
+1
New +$13.4K ﹤0.01% 2517
2013
Q3 		– Hold
0
– -$3K – 4786
2013
Q2 		– Hold
0
– – – 3320

Other funds holding RDHL

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $4.98B AUM 22.72% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tower Research Capital (TRC)'s RDHL Position: Q2 2023 in Review

Tower Research Capital (TRC) held its Redhill Biopharma (RDHL) position steady in Q2 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6310.

Tower Research Capital (TRC) first reported a position in RDHL in Q1 2014 and has held it in 16 quarters since. The position peaked at $123K in Q3 2021. 18 funds tracked by Wall St. Rank hold RDHL as of Q2 2023.

  • Tower Research Capital (TRC) held 0 shares of Redhill Biopharma worth $0 as of Q2 2023.
  • Tower Research Capital (TRC) left its Redhill Biopharma share count unchanged in Q2 2023.
  • Redhill Biopharma made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2023, its #6310 holding.
  • Tower Research Capital (TRC) first reported a position in Redhill Biopharma in Q1 2014 and has held it in 16 quarters since.
  • Tower Research Capital (TRC)'s Redhill Biopharma position peaked at $123K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.